Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2023-08-09 Sale | 2023-08-11 4:25 pm | Cyclerion Therapeutics Inc. | CYCN | MCGUIRE TERRANCE Director | 8 | $3.395 | $27 | 37,010 (Indirect Direct) | View |
2021-06-03 Purchase | 2021-06-07 5:36 pm | Cyclerion Therapeutics Inc. | CYCN | MCGUIRE TERRANCE Director | 96,153 | $3.12 | $299,997 | 43,077 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-08-05 Option Award | 2024-08-07 4:05 pm | N/A 2034-08-05 | Cyclerion Therapeutics Inc. | CYCN | Graul Regina Margaret See Remarks | 55,849 | $0 | 55,849 (Direct) | View |
Ownership | 2024-03-11 4:05 pm | N/A N/A | Cyclerion Therapeutics Inc. | CYCN | CHICKO RHONDA M. Chief Financial Officer | 0 | $0 | 18 (Direct) | View |
2024-01-01 Option Award | 2024-01-26 4:07 pm | N/A N/A | Cyclerion Therapeutics Inc. | CYCN | Hecht Peter M Director 10% Owner | 15,000 | $0 | 377,457 (Direct) | View |
2024-01-01 Option Award | 2024-01-26 4:05 pm | N/A N/A | Cyclerion Therapeutics Inc. | CYCN | Graul Regina Margaret President | 50,000 | $0 | 100,303 (Direct) | View |
Ownership | 2023-12-11 5:09 pm | N/A N/A | Cyclerion Therapeutics Inc. | CYCN | Katabi Dina Director | 0 | $0 | 20,000 (Direct) | View |
Ownership | 2023-12-07 4:05 pm | N/A N/A | Cyclerion Therapeutics Inc. | CYCN | Higgins Michael J Director | 0 | $0 | 21,650 (Direct) | View |
Ownership(A) | 2023-12-07 4:05 pm | N/A N/A | Cyclerion Therapeutics Inc. | CYCN | Graul Regina Margaret President | 0 | $0 | 50,303 (Direct) | View |
Ownership | 2023-12-04 4:05 pm | N/A N/A | Cyclerion Therapeutics Inc. | CYCN | Graul Regina Margaret President | 0 | $0 | 50,000 (Direct) | View |
2023-11-30 Option Award | 2023-12-04 4:05 pm | N/A N/A | Cyclerion Therapeutics Inc. | CYCN | MCGUIRE TERRANCE Director | 5,000 | $0 | 42,010 (Direct) | View |
2023-11-30 Option Award | 2023-12-04 4:05 pm | N/A N/A | Cyclerion Therapeutics Inc. | CYCN | Hecht Peter M Director 10% Owner | 35,000 | $0 | 362,457 (Direct) | View |
2023-11-30 Option Award | 2023-12-04 4:05 pm | N/A N/A | Cyclerion Therapeutics Inc. | CYCN | DESOUZA ERROL B Director | 50,000 | $0 | 30,000 (Direct) | View |
2023-11-30 Option Award | 2023-12-04 4:04 pm | N/A N/A | Cyclerion Therapeutics Inc. | CYCN | Hyman Steven Director | 20,000 | $0 | 20,000 (Direct) | View |
2023-05-19 Option Award | 2023-05-22 8:43 pm | N/A N/A | Cyclerion Therapeutics Inc. | CYCN | Hecht Peter M Chief Executive Officer 10% Owner | 576,037 | $8.68 | 678,494 (Direct) | View |
2022-07-25 Option Award(A) | 2022-07-27 4:40 pm | N/A 2032-07-25 | Cyclerion Therapeutics Inc. | CYCN | Hyman Steven Director | 57,753 | $0 | 57,753 (Direct) | View |
2022-07-25 Option Award | 2022-07-26 4:33 pm | N/A 2032-07-25 | Cyclerion Therapeutics Inc. | CYCN | Hyman Steven Director | 57,753 | $0 | 57,753 (Direct) | View |
Ownership | 2022-07-26 4:30 pm | N/A N/A | Cyclerion Therapeutics Inc. | CYCN | Hyman Steven Director | 0 | $0 | 0 (Direct) | View |
2022-06-14 Option Award | 2022-06-16 8:56 pm | N/A 2032-06-14 | Cyclerion Therapeutics Inc. | CYCN | MCGUIRE TERRANCE Director | 20,000 | $0 | 20,000 (Direct) | View |
2022-06-14 Option Award | 2022-06-16 8:56 pm | N/A 2032-06-14 | Cyclerion Therapeutics Inc. | CYCN | Mendelsohn Michael Director | 20,000 | $0 | 20,000 (Direct) | View |
2022-06-14 Option Award | 2022-06-16 8:56 pm | N/A 2032-06-14 | Cyclerion Therapeutics Inc. | CYCN | Fanucci Marsha Director | 20,000 | $0 | 20,000 (Direct) | View |
2022-06-14 Option Award | 2022-06-16 8:56 pm | N/A 2032-06-14 | Cyclerion Therapeutics Inc. | CYCN | Lovell Stephanie Director | 20,000 | $0 | 20,000 (Direct) | View |
2022-06-14 Option Award | 2022-06-16 8:56 pm | N/A 2032-06-14 | Cyclerion Therapeutics Inc. | CYCN | CONRADES GEORGE H Director | 20,000 | $0 | 20,000 (Direct) | View |
2022-06-14 Option Award | 2022-06-16 8:55 pm | N/A 2032-06-14 | Cyclerion Therapeutics Inc. | CYCN | Isacson Ole Director | 20,000 | $0 | 20,000 (Direct) | View |
2022-06-14 Option Award | 2022-06-16 8:55 pm | N/A 2032-06-14 | Cyclerion Therapeutics Inc. | CYCN | DESOUZA ERROL B Director | 20,000 | $0 | 20,000 (Direct) | View |
2022-01-20 Option Award | 2022-01-24 11:48 am | N/A 2032-01-20 | Cyclerion Therapeutics Inc. | CYCN | Busch Andreas Chief Scientific Officer | 135,000 | $0 | 135,000 (Direct) | View |
2022-01-20 Option Award | 2022-01-24 11:43 am | N/A 2032-01-20 | Cyclerion Therapeutics Inc. | CYCN | Gjino Anjeza Chief Financial Officer | 135,000 | $0 | 135,000 (Direct) | View |
2022-01-03 Option Award | 2022-01-24 11:38 am | N/A 2032-01-03 | Cyclerion Therapeutics Inc. | CYCN | Hecht Peter M Chief Executive Officer | 482,950 | $0 | 482,950 (Direct) | View |
2022-01-20 Option Award | 2022-01-24 11:33 am | N/A 2032-01-20 | Cyclerion Therapeutics Inc. | CYCN | Gault Cheryl Chief Operating Officer | 135,000 | $0 | 135,000 (Direct) | View |
2021-12-09 Option Award | 2021-12-10 4:32 pm | N/A 2031-12-09 | Cyclerion Therapeutics Inc. | CYCN | Busch Andreas Chief Scientific Officer | 75,000 | $0 | 75,000 (Direct) | View |
2021-12-09 Option Award | 2021-12-10 4:31 pm | N/A 2031-12-09 | Cyclerion Therapeutics Inc. | CYCN | Gjino Anjeza Chief Financial Officer | 100,000 | $0 | 100,000 (Direct) | View |
2021-12-09 Option Award | 2021-12-10 4:31 pm | N/A 2031-12-09 | Cyclerion Therapeutics Inc. | CYCN | Gault Cheryl Chief Operating Officer | 100,000 | $0 | 100,000 (Direct) | View |
2021-06-24 Option Award | 2021-06-28 5:27 pm | N/A 2031-06-24 | Cyclerion Therapeutics Inc. | CYCN | Lovell Stephanie Director | 10,000 | $0 | 10,000 (Direct) | View |
2021-06-24 Option Award | 2021-06-28 5:25 pm | N/A 2031-06-24 | Cyclerion Therapeutics Inc. | CYCN | Fanucci Marsha Director | 10,000 | $0 | 10,000 (Direct) | View |
2021-06-24 Option Award | 2021-06-28 5:22 pm | N/A 2031-06-24 | Cyclerion Therapeutics Inc. | CYCN | Isacson Ole Director | 10,000 | $0 | 10,000 (Direct) | View |
2021-06-24 Option Award | 2021-06-28 5:17 pm | N/A 2031-06-24 | Cyclerion Therapeutics Inc. | CYCN | Churchwell Kevin Director | 10,000 | $0 | 10,000 (Direct) | View |
2021-06-24 Option Award | 2021-06-28 5:14 pm | N/A 2031-06-24 | Cyclerion Therapeutics Inc. | CYCN | Mendelsohn Michael Director | 10,000 | $0 | 10,000 (Direct) | View |
2021-06-24 Option Award | 2021-06-28 5:11 pm | N/A 2031-06-24 | Cyclerion Therapeutics Inc. | CYCN | CONRADES GEORGE H Director | 10,000 | $0 | 10,000 (Direct) | View |
2021-06-24 Option Award | 2021-06-28 5:08 pm | N/A 2031-06-24 | Cyclerion Therapeutics Inc. | CYCN | DESOUZA ERROL B Director | 10,000 | $0 | 10,000 (Direct) | View |
2021-06-24 Option Award | 2021-06-28 5:05 pm | N/A 2031-06-24 | Cyclerion Therapeutics Inc. | CYCN | MCGUIRE TERRANCE Director | 10,000 | $0 | 10,000 (Direct) | View |